Research Article
[Retracted] G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
Table 1
Characteristics information table of HCC patients.
| Characteristic | Low expression of GNG5 | High expression of GNG5 | |
| | 187 | 187 | | T stage, (%) | | | 0.217 | T1 | 99 (26.7%) | 84 (22.6%) | | T2 | 42 (11.3%) | 53 (14.3%) | | T3 | 39 (10.5%) | 41 (11.1%) | | T4 | 4 (1.1%) | 9 (2.4%) | | N stage, (%) | | | 0.122 | N0 | 127 (49.2%) | 127 (49.2%) | | N1 | 0 (0%) | 4 (1.6%) | | M stage, (%) | | | 1.000 | M0 | 132 (48.5%) | 136 (50%) | | M1 | 2 (0.7%) | 2 (0.7%) | | Pathologic stage, (%) | | | 0.273 | Stage I | 96 (27.4%) | 77 (22%) | | Stage II | 39 (11.1%) | 48 (13.7%) | | Stage III | 39 (11.1%) | 46 (13.1%) | | Stage IV | 2 (0.6%) | 3 (0.9%) | | Gender, (%) | | | 0.047 | Female | 51 (13.6%) | 70 (18.7%) | | Male | 136 (36.4%) | 117 (31.3%) | | Age, (%) | | | 0.133 | ≤60 | 81 (21.7%) | 96 (25.7%) | | >60 | 106 (28.4%) | 90 (24.1%) | | Histologic grade, (%) | | | 0.002 | G1 | 35 (9.5%) | 20 (5.4%) | | G2 | 97 (26.3%) | 81 (22%) | | G3 | 51 (13.8%) | 73 (19.8%) | | G4 | 2 (0.5%) | 10 (2.7%) | |
|
|